McIlrath & Eck’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $182K | Buy |
671
+3
| +0.4% | +$893 | 0.01% | 271 |
|
|
2025
Q4 | $220K | Buy |
668
+22
| +3% | +$7.46K | 0.02% | 153 |
|
|
2025
Q3 | $223K | Buy |
646
+329
| +104% | +$99.5K | 0.02% | 136 |
|
|
2025
Q2 | $98.9K | Sell |
317
-13
| -4% | -$4.97K | 0.01% | 203 |
|
|
2025
Q1 | $173K | Sell |
330
-11
| -3% | -$5.62K | 0.02% | 140 |
|
|
2024
Q4 | $173K | Sell |
341
-294
| -46% | -$167K | 0.02% | 129 |
|
|
2024
Q3 | $371K | Buy |
635
+48
| +8% | +$27.1K | 0.05% | 89 |
|
|
2024
Q2 | $299K | Buy |
587
+33
| +6% | +$16.2K | 0.04% | 95 |
|
|
2024
Q1 | $274K | Buy |
554
+12
| +2% | +$6.1K | 0.04% | 100 |
|
|
2023
Q4 | $285K | Buy |
542
+5
| +0.9% | +$2.67K | 0.05% | 96 |
|
|
2023
Q3 | $271K | Hold |
537
| – | – | 0.05% | 98 |
|
|
2023
Q2 | $258K | Buy |
537
+18
| +3% | +$8.8K | 0.05% | 96 |
|
|
2023
Q1 | $245K | Buy |
519
+77
| +17% | +$37.2K | 0.06% | 97 |
|
|
2022
Q4 | $234K | Buy |
442
+9
| +2% | +$4.77K | 0.06% | 92 |
|
|
2022
Q3 | $219K | Buy |
433
+159
| +58% | +$83.6K | 0.06% | 91 |
|
|
2022
Q2 | $141K | Hold |
274
| – | – | 0.04% | 105 |
|
|
2022
Q1 | $140K | Buy |
274
+97
| +55% | +$46.8K | 0.04% | 101 |
|
|
2021
Q4 | $89K | Sell |
177
-50
| -22% | -$22.6K | 0.02% | 163 |
|
|
2021
Q3 | $89K | Buy |
227
+17
| +8% | +$7.04K | 0.03% | 153 |
|
|
2021
Q2 | $84K | Buy |
210
+1
| +0.5% | +$399 | 0.03% | 179 |
|
|
2021
Q1 | $78K | Buy |
209
+39
| +23% | +$13.5K | 0.03% | 146 |
|
|
2020
Q4 | $60K | Buy |
170
+13
| +8% | +$4.36K | 0.02% | 154 |
|
|
2020
Q3 | $49K | Buy |
157
+17
| +12% | +$5.22K | 0.02% | 150 |
|
|
2020
Q2 | $41K | Sell |
140
-9
| -6% | -$2.58K | 0.02% | 149 |
|
|
2020
Q1 | $37K | Buy |
149
+36
| +32% | +$9.91K | 0.02% | 144 |
|
|
2019
Q4 | $33K | Buy |
113
+23
| +26% | +$6.02K | 0.02% | 177 |
|
|
2019
Q3 | $20K | Hold |
90
| – | – | 0.01% | 214 |
|
|
2019
Q2 | $22K | Hold |
90
| – | – | 0.01% | 184 |
|
|
2019
Q1 | $22K | Sell |
90
-4
| -4% | -$1.02K | 0.01% | 184 |
|
|
2018
Q4 | $23K | Hold |
94
| – | – | 0.01% | 175 |
|
|
2018
Q3 | $25K | Hold |
94
| – | – | 0.01% | 185 |
|
|
2018
Q2 | $23K | Sell |
94
-42
| -31% | -$10.1K | 0.01% | 184 |
|
|
2018
Q1 | $29K | Hold |
136
| – | – | 0.02% | 148 |
|
|
2017
Q4 | $30K | Buy |
+136
| New | +$28.8K | 0.02% | 160 |
|
Other funds holding UNH
VCM
VPM
McIlrath & Eck's UNH Position: Q1 2026 in Review
McIlrath & Eck increased its UnitedHealth (UNH) stake by 0.45% in Q1 2026, buying an estimated $893 and bringing the position to 671 shares worth $182K. The position accounts for 0.01% of the portfolio, ranked #271.
McIlrath & Eck first reported a position in UNH in Q4 2017 and has held it in 34 quarters since. The position peaked at $371K in Q3 2024. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- McIlrath & Eck held 671 shares of UnitedHealth worth $182K as of Q1 2026.
- McIlrath & Eck bought 3 UnitedHealth shares in Q1 2026, an estimated $893.
- UnitedHealth made up 0.01% of McIlrath & Eck's portfolio in Q1 2026, its #271 holding.
- McIlrath & Eck first reported a position in UnitedHealth in Q4 2017 and has held it in 34 quarters since.
- McIlrath & Eck's UnitedHealth position peaked at $371K in Q3 2024.
- 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.